Immunicum Presents Data on Clinical Program DCP-001 at the European Hematology Association (EHA) 2021 Virtual Congress
Immunicum Presents Data on Clinical Program DCP-001 at the European Hematology Association (EHA) 2021 Virtual…
Immunicum Presents Data on Clinical Program DCP-001 at the European Hematology Association (EHA) 2021 Virtual…
New pivotal data at EHA 2021 reinforces sutimlimab as a first-in-class investigational…
– Company Expects to File for Regulatory Approval for Mitapivat for the Treatment of Adults…
First-in-class, oral, targeted factor B inhibitor iptacopan substantially reduced both intra- and extravascular hemolysis when…
Final data from 93-patient Phase 2a clinical trial show lower annualized rate of vaso-occlusive crises…
– Study Met Primary Endpoint; Treatment with Mitapivat Induced Hemoglobin Increase of ≥1.0 g/dL in…
Robust decreases in serum IgM at low- and mid-doses suggest best-in-class potential for mavorixafor plus…
Analysis from Phase 2a HOPE-KIDS 1 Study Featured in Oral Presentation Two Real-world Data Studies…
Four-year follow-up analysis from the phase III CLL14 study showed progression-free survival rate of 74.0%…
Data from JEWELFISH, the first trial in a diverse population aged 1 to 60 years…
Listing Transition to Proceed as Previously Announced to Maintain Regulatory Compliance as a U.S.-Based, Plant-Touching…
Preclinical candidate is second to demonstrate selective blocking ability from in-house panel of antibodies targeting…
BELTSVILLE, Md., June 10, 2021 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical…
CAMBRIDGE, Mass., June 10, 2021 (GLOBE NEWSWIRE) — Biogen Inc. (Nasdaq: BIIB) announced today that…
Submitted first premarket approval (PMA) application in the Company’s history to FDA for LungFit® PH…
– Webinar on Monday, June 21, 2021 at 11:00 a.m. ET – MONTREAL, June 10,…
VANCOUVER, British Columbia, June 10, 2021 (GLOBE NEWSWIRE) — Segra International Corp, a leading cannabis…
SUWON, Republic of Korea, June 10, 2021 (GLOBE NEWSWIRE) — OliX Pharmaceuticals, Inc. (KOSDAQ: 226950),…
Astronomy Meets Pathology for Immunotherapy Research The Johns Hopkins AstroPath™ team used Akoya’s Phenoptics technology…
Online Event Scheduled for Monday, June 21, 2021 at 2:00 p.m., ET Event to Spotlight…